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Glucose repression/derepression in budding yeast: SNF1 protein
kinase is activated by phosphorylation under derepressing
conditions, and this correlates with a high AMP:ATP ratio
Wayne A. Wilson*, Simon A. Hawley and D. Grahame Hardie
Background: Genetic studies of Saccharomyces cerevisiae have shown that
Snf1p and Snf4p, which together form the SNF1 complex, are essential for gene
derepression on removal of glucose from the medium. However the metabolic
signal(s) involved, and the exact role of SNF1, have remained enigmatic. Recently,
the AMP-activated protein kinase (AMPK) was shown to be the mammalian
homologue of SNF1. AMPK is activated by the elevation of the cellular AMP:ATP
ratio, which occurs during cellular stress in mammalian cells. The mechanism of
activation involves phosphorylation of AMPK by an upstream protein kinase
(AMPKK). We have investigated whether a similar mechanism might explain the
role of SNF1 in yeast in the response to the stress of glucose starvation.
Results: The protein kinase activity of SNF1 was dramatically and rapidly activated
by phosphorylation on removal of glucose from the medium. SNF1 was not
activated directly by AMP, but could be inactivated by protein phosphatases and
reactivated by mammalian AMPKK. We also demonstrated that an endogenous
SNF1-reactivating factor, most likely an upstream protein kinase, is present in yeast
extracts. Under a variety of different growth conditions, there was a correlation
between cellular adenine nucleotide levels and the activation state of SNF1.
Conclusions: Apart from the lack of direct allosteric activation of SNF1 by AMP,
the regulation of the mammalian AMPK and yeast SNF1 protein kinase cascades
is highly conserved. Adenine nucleotides are now good candidates for metabolic
signals which indicate the lack of glucose in the medium, triggering activation of
SNF1 and derepression of glucose-repressed genes.
Background
Glucose repression (catabolite repression) is the phenome-
non whereby high levels of glucose repress the expression
of specific genes. In Saccharomyces cerevisiae, glucose-
repressed genes include those required for oxidative metab-
olism, and for metabolism of alternative carbon sources,
such as sucrose, maltose and galactose [1,2]. The SNF1
gene (also known as CCR1 or CAT1) is essential for dere-
pression of these genes [3–5], and sequencing and expres-
sion studies have revealed that SNF1 encodes a protein
kinase [6]. SNF1 homologues have been cloned from higher
plants; these rescue snf1 mutations in yeast [7,8], suggesting
that this gene family is of wide relevance to the regulation
of gene expression in eukaryotes.
Mutations in the yeast SNF4 (CAT3 [9]) gene have essen-
tially the same phenotype as those in SNF1, and functional
SNF4 is essential for the protein kinase activity of Snf1p
[10,11]. Snf1p and Snf4p form a complex in vitro and in vivo
[12–14]. In this paper, we use the term SNF1 to refer to the
minimal complex comprising Snf1p and Snf4p. Carlson’s
group have also defined three other genes (SIP1, SIP2 and
GAL83) whose products interact with Snf1p via a conserved
carboxy-terminal region (the ASC domain) [15]. Although
not essential for derepression, these are proposed to be
‘adaptor’ or ‘targeting’ subunits which direct the SNF1
complex to specific downstream targets.
The mammalian homologue of SNF1 is the AMP-activated
protein kinase (AMPK) [16,17], which phosphorylates a
number of targets in vitro and in vivo [18]. A current
hypothesis for the function of the AMPK system is that it
acts as a cellular ‘fuel gauge’, switching off non-essential
pathways in response to environmental stresses which
deplete ATP [19]. Depletion of ATP causes elevation of
the AMP:ATP ratio by displacement of the adenylate
kinase reaction, and this activates AMPK via direct
allosteric activation [20,21] and by multiple mechanisms
which promote phosphorylation of AMPK by an upstream
protein kinase, AMPK kinase (AMPKK) [22,23]. AMPK is
a 1:1:1 complex formed from a catalytic a subunit and non-
catalytic b and g subunits (formerly p63, p38 and p35) [24].
Cloning and sequencing of cDNAs encoding these sub-
units revealed a close similarity between AMPK-a and
Snf1p, AMPK-g and Snf4p, and AMPK-b and the ASC
domains of Sip1p, Sip2p and Gal83p [17,25–27]. Thus, the
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S. cerevisiae SNF1 complex and the mammalian AMPK
complex are highly conserved at the structural level. At first
sight, their physiological functions might appear to be dif-
ferent, but this may simply reflect the different approaches
through which they were discovered. The substrate speci-
ficities of the two protein kinases are closely related [28],
and they share at least one physiological substrate, acetyl-
CoA carboxylase [10,16,29].
The metabolic signal(s) which trigger glucose repression/
derepression in S. cerevisiae, or indeed in any eukaryote,
remain enigmatic [2]. The mechanism by which SNF1
mediates derepression is also unclear. By contrast, both the
metabolic signal and the mechanism by which AMPK is
activated in response to environmental stress in mammalian
cells are well understood [18]. High ratios of AMP:ATP
activate the system in part through direct allosteric activa-
tion of AMPK, but also by stimulating phosphorylation and
activation of AMPK by AMPKK. The high degree of
sequence similarity between the AMPK and SNF1 com-
plexes suggested that SNF1 might be activated by phos-
phorylation in response to glucose starvation, and that AMP
might be a signal involved in this event.
Results
Assay of SNF1 protein kinase in yeast extracts
In order to assay SNF1 activity in a crude yeast extracts, we
measured the phosphorylation of the ‘SAMS’ peptide
(HMRSAMSGLHLVKRR; single-letter amino-acid code),
which was developed originally for the assay of mammalian
AMPK [30]. If cells were harvested under derepressing con-
ditions, the activity in the wild-type strain MCY1094 was
greater than 10-fold higher than that in a snf1-disrupted
strain in the same genetic background (MCY1828; Fig.1a).
This result confirmed that the SAMS peptide was a reason-
ably specific substrate for SNF1, although there was a low
background of peptide phosphorylation in the knockout
strain. Figure 1a also shows that there was a very large acti-
vation of SNF1 protein kinase in cells transferred to dere-
pressing conditions (0.05 % glucose) compared with
repressing conditions (2 % glucose). The greater than 10-
fold difference between the snf1-disrupted and the wild-
type strain was only seen under derepressing conditions. In
cells maintained in high glucose, the apparent SNF1 activ-
ity in the wild-type was identical to the low, background
activity in the knockout strain. The low basal activity in the
wild-type strain is therefore likely to be due to other protein
kinases which slowly phosphorylate the SAMS peptide.
In order to observe the large activation of SNF1 on transfer
to derepressing conditions, the method of harvesting the
cells was critical. Figure 1b shows experiments conducted
with yeast strain ABYS106, which was used for subsequent
purification of SNF1. The large difference in activity
between repressing and derepressing conditions was
observed only if cells were harvested by rapid membrane
filtration and immediately frozen in liquid nitrogen. If
cells were harvested in the conventional manner — by
centrifugation and resuspension in homogenization
medium lacking glucose — the peptide kinase activity
was as high under repressing conditions as it was under
derepressing conditions.
The dramatic activation of SNF1 observed on transfer from
repressing to derepressing conditions appears to be due to
phosphorylation, because it was completely reversed by
incubating the extracts with the homogeneous catalytic
subunit of mammalian protein phosphatase-2A (PP2A; Fig.
1c). This effect was prevented by the addition of the PP2A
inhibitor, okadaic acid. PP2A had no significant effect on
the low basal activity observed in extracts made by rapid
filtration under repressing conditions.
Purification and properties of SNF1 protein kinase
The SNF1 complex was purified by a modification of the
method of Mitchelhill et al. [16], which exploits the ability
of a polyhistidine stretch near the amino terminus of Snf1p
to bind to Ni2+–Sepharose. Peptide kinase activity was
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Figure 1
‘SAMS’ peptide kinase activity measured in yeast extracts. (a) Activity
in a snf1-disrupted strain (MCY1828 snf1-D10) compared with a wild-
type with the same genetic background (MCY1094). (b) activity in
extracts of strain ABYS106 harvested by rapid filtration and freezing
(‘filtration’; see Materials and methods), or by centrifugation (2000 × g,
2 min) followed by resuspension in homogenization buffer and
immediate homogenization (‘centrifugation’). (c) Cells of strain
ABYS106 were harvested by rapid filtration, extracts prepared, and the
extracts were incubated at 30 °C for 10 min with mammalian protein
phosphatase-2A (PP2A; 10 U ml–1) either in the presence or absence
of 100 nM okadaic acid (OA). In all three experiments, extracts were
derived from cells in mid-log phase which had been maintained in 2 %
glucose, harvested by centrifugation, then incubated for a further
15 min in medium containing either 2 % or 0.05 % glucose.
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purified 5700-fold with a final specific activity of
1.21 mmol min–1 mg–1. Fractions from the leading edge of
the kinase peak from the Ni2+–Sepharose column were not
pure, but silver staining of fractions from the trailing edge
detected only two polypeptides, of 72 and 36 kDa, which
cross-reacted on blots with antibodies directed against
Snf1p and Snf4p, respectively (data not shown). There was
no evidence for stoichiometric quantities of a third subunit,
corresponding to Sip1p, Sip2p or Gal83p, although it is pos-
sible that these are not readily detectable by silver staining.
Concentrations of AMP up to 200 mM had no effect on the
peptide kinase activity of purified SNF1. A wide range of
sugar phosphates, including glucose-6-phosphate, 2-deoxy-
glucose-6-phosphate, glucose-1-phosphate, glucose-1,6-bis-
phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate,
fructose-2,6-bisphosphate, dihydroxyacetone phosphate,
xylulose-5-phosphate and ribulose-5-phosphate, were also
without effect at concentrations up to 8 mM.
Regulation of SNF1 by reversible phosphorylation
Although we could find no evidence for allosteric regula-
tion, purified SNF1 was inactivated in a time-dependent
manner by incubation with the homogeneous catalytic
subunits of mammalian protein phosphatases-1, -2A or -
2C (PP1, PP2A or PP2C). As expected, inactivation by
PP1 or PP2A was blocked by 100 nM okadaic acid, and
inactivation by PP2C was dependent on the presence of
Mg2+ (data not shown). Purified SNF1 inactivated by
PP2A treatment did not reactivate on the addition of
MgATP, either in the presence or absence of AMP.
However, a time-dependent reactivation was observed
when MgATP plus partially purified mammalian AMPKK
were added, in a reaction that was stimulated by 100 mM
AMP (Fig. 2a). Unfortunately, a high level of background
phosphorylation in the AMPKK preparation prevented
confirmation that this was associated with phosphoryla-
tion of Snf1p.
The results in Figure 2a show that homogeneous SNF1
kinase did not reactivate after dephosphorylation when
MgATP alone was added (such reactivation would indicate
an autophosphorylation reaction). By contrast, SNF1 puri-
fied from derepressed cells only as far as the DEAE–
Sepharose step could be reactivated after dephosphoryla-
tion on addition of MgATP alone (Fig. 2b). We attempted
to study the effects of AMP in this crude reactivation
assay, but analysis of nucleotide levels at the end of the
incubations indicated that substantial quantities of AMP
were being generated even when it had not been added
(data not shown). The same range of sugar phosphates
tested as allosteric activators of SNF1 (see above) were
also without effect in this reactivation assay. SNF1 par-
tially purified in the same way from repressed cells would
not reactivate in the presence of MgATP (Fig. 2b).
Further studies on the regulation of SNF1 kinase activity 
in vivo
As described above, when glucose was removed from the
medium, the protein kinase activity of SNF1 was con-
verted from an inactive to an active state by phosphoryla-
tion. This activation of SNF1 was extremely rapid, being
essentially maximal in the minimum time (5 minutes)
required for cell harvesting, and persisting for up to
60 minutes (Fig. 3a). When high glucose was added back
to cells that had been transiently starved for glucose, acti-
vation of SNF1 was reversed completely within 5 minutes
(data not shown). Figure 4a shows the dependence of
SNF1 activity on the glucose concentration in the medium.
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Figure 2
Inactivation of SNF1 by PP2A and reactivation by (a) mammalian
AMPKK and (b) endogenous yeast SNF1-reactivating factor (SRF). 
(a) SNF1 purified on Ni2+–Sepharose was inactivated by treatment
with PP2A. At the point shown by the arrow, okadaic acid (100 nM)
was added to inhibit further dephosphorylation, together with MgATP.
Further additions were either none (open circles), 100 mM AMP (open
squares), AMPKK (filled circles) or 100 mM AMP and AMPKK (filled
squares). (b) SNF1 purified through the DEAE–Sepharose step from
cells harvested under derepressing conditions (0.05 % glucose, open
symbols) or repressing conditions (2 % glucose, filled symbols) were
incubated with mammalian PP2A. At the point shown by the arrow,
okadaic acid (100 nM) and NaF (50 mM) were added. Further
additions were MgCl2 (squares), or MgCl2 plus ATP (circles). See
Materials and methods for further details.
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The activation of SNF1 upon glucose removal is analogous
to the rapid activation of its mammalian homologue,
AMPK, which occurs in response to changes in AMP and
ATP in cells subjected to heat stress or chemical stress
[19]. We therefore investigated whether glucose removal
from the medium was associated with changes in adenine
nucleotide levels. Figure 5 shows an analysis, by high per-
formance liquid chromatography (HPLC), of perchloric
acid extracts of cells that had been resuspended in
medium with high (2 %) or low (0.05 %) levels of glucose
and further incubated for 15 minutes. Because of slight
variation in the absolute recovery of nucleotides between
replicates, we found it more reproducible to express the
results as ratios. In control cells maintained in high
glucose, there was a high ratio of ATP:ADP (5.3 ± 0.8;
n = 13), and AMP was very low (ATP:AMP: 23 ± 3; n = 13).
However in cells incubated in low glucose for 15 minutes,
the ADP:ATP ratio had increased 18 ± 4-fold (n = 3), and
the AMP:ATP had increased 220 ± 19-fold (n = 3).
The correlation between these nucleotide ratios and
SNF1 activity was examined in two experimental proto-
cols — a time course after readdition of 2 % glucose, and a
concentration dependence after readdition of glucose for
15 minutes (Figs 3,4). When high glucose levels were
added back to cells which had been transiently starved in
0.05 % glucose, both the activation of SNF1 kinase activ-
ity and the increase in the AMP:ATP and ADP:ATP ratios
were essentially complete by 5 minutes, which was the
minimum time required for cell harvesting (Fig. 3). These
parameters also varied over the same range of glucose
concentrations (0–60 mM), although the effect on the
Figure 3
Time courses of changes in (a) SNF1 kinase activity and (b)
nucleotide ratios on transfer from repressing to derepressing
conditions. Cells were grown in 2 % glucose, spun down, and
resuspended in 0.05 % glucose (open symbols), or 2 % glucose (filled
symbols) for the times indicated (which includes the time required for
cell harvesting). The dotted line in (a) shows, for comparison, the
kinase activity in extracts of the MCY1828 snf1-D10 strain. Nucleotide
ratios in (b) are expressed relative to the ratio in cells under repressing
conditions at time zero. AMP:ATP ratios are represented by circles and
ADP:ATP ratios by squares.
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Figure 4
Dependence of (a) SNF1 kinase activity and (b) nucleotide ratios on
glucose concentration in the medium. Cells were transferred from
derepressing medium (0.05 % glucose) to medium containing the
glucose concentration shown for 15 min. The dotted line in (a) shows,
for comparison, the kinase activity in extracts of the MCY1828 snf1-
D10 strain. Nucleotide ratios in (b) are expressed relative to the ratios
in cells transferred to 120 mM glucose. AMP:ATP ratios are
represented by circles and ADP:ATP ratios by squares.
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AMP:ATP and ADP:ATP ratios was half-maximal at a
slightly lower medium glucose (approximately 15 mM)
than the effect on kinase activity (approximately 30 mM)
(Fig. 4). SNF1 activity and nucleotide ratios also correlated
under other conditions (data not shown): for example,
when glucose was replaced by sucrose (the rise in both
parameters was transient due to derepression of invertase,
which allows eventual conversion of sucrose to glucose),
and when cells harvested by centrifugation or rapid filtra-
tion were compared (see Fig. 1b).
Discussion
At least four novel and potentially important observations
have emerged from this study. First, the protein kinase
activity of SNF1 can be measured in crude yeast extracts
using the SAMS peptide, although the method of cell har-
vesting is critical if the state of activation of the kinase is
to be preserved. Second, the protein kinase activity of
SNF1 is increased rapidly and dramatically by the
removal of glucose from the medium, and this is due to
phosphorylation, most likely of Snf1p itself. Third, a
SNF1-reactivating factor (SRF) exists in yeast: as it
reverses the effect of dephosphorylation and can be mim-
icked by mammalian AMPKK, it is most likely to be an
upstream protein kinase. Fourth, under a variety of differ-
ent growth conditions there is a correlation between the
AMP:ATP ratio (and the ADP:ATP ratio) and SNF1
kinase activity in vivo, making these adenine nucleotides
good candidates to be the metabolic signals that trigger
derepression of glucose-repressed genes.
Unlike AMPK, homogeneous SNF1 was not activated
allosterically by AMP, in agreement with previous studies
using partially purified enzyme [10]. However, SNF1 does
share with AMPK the ability to be inactivated by dephos-
phorylation (catalyzed by mammalian PP1, PP2A or PP2C)
and reactivated by phosphorylation (Fig. 2). The PP2A-
inactivated form of SNF1 purified on the Ni2+ column was
not reactivated on addition of MgATP alone, but could be
reactivated on addition of MgATP plus purified mam-
malian AMPKK. This suggests that reactivation of SNF1 in
vivo may also be catalyzed by a distinct, upstream protein
kinase rather than by autophosphorylation. We have
reported recently that the site phosphorylated on AMPK-a
by AMPKK is the threonine at position 172 (T172) [31],
which lies in the ‘activation segment’ where many other
protein kinases are activated by phosphorylation [32]. The
equivalent residue in Snf1p is T210, and mutation of this
residue to alanine has already been shown to result in com-
plete loss of SNF1 function in vivo [13]. These results
suggest that T172 and T210 represent the activating phos-
phorylation sites in AMPK-a and Snf1p, respectively.
Although SNF1 purified through the Ni2+–Sepharose
column did not reactivate after PP2A treatment on addition
of MgATP alone, but kinase purified only as far as the
DEAE–Sepharose column did reactivate (Fig. 2) — sug-
gesting that the Ni2+–Sepharose column removes an
endogenous SRF. As SRF reverses the effect of dephos-
phorylation, and can be mimicked by mammalian AMPKK,
it is likely to be an upstream protein kinase, although we
cannot yet formally rule out the possibility that it represents
a factor necessary for autophosphorylation. No evidence for
a protein kinase upstream of SNF1 has yet emerged either
from classical genetic screens or from two-hybrid screens.
The ability to measure not only the protein kinase activity
of the SNF1 complex, but also its inactivation by dephos-
phorylation and reactivation by SRF, provides new assays
with which to search for the unknown metabolic signal(s)
that trigger glucose repression and derepression. Although
purified SNF1 was not activated allosterically by AMP, in
the mammalian system this nucleotide also promotes phos-
phorylation of AMPK by AMPKK via multiple mecha-
nisms [22,23]. Most, if not all, of these effects of AMP are
antagonized by high concentrations of ATP, so that the key
signal is the AMP:ATP ratio rather than AMP per se. These
observations raise the possibility that elevation of AMP (or
the AMP:ATP ratio) might also be a signal for activation of
the SNF1 protein kinase cascade, but that it might operate
by promoting phosphorylation, rather than by allosteric
activation, of SNF1. We did study the effects of AMP on
reactivation by endogenous SRF in the crude system
shown in Figure 2b. However, when assays performed
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Figure 5
Analysis of cellular nucleotides by ion exchange HPLC. Cells adapted
to growth in high glucose were spun down and resuspended in 2 %
glucose (top panel) or 0.05 % glucose (bottom panel). After 15 min,
nucleotides were extracted, and analysed by HPLC. The continuous
line shows absorbance at 260 nm. Peaks of AMP, ADP and ATP are
indicated and were identified by co-migration with standards, in the
case of AMP this being a [3H]AMP internal standard. The dotted line
shows the percentage of the high ionic strength buffer [19] in the
eluant. See Materials and methods for more details.
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without AMP were analyzed to determine their nucleotide
content, it was clear that substantial quantities of AMP
were being generated during the assay. This is most likely
due to contamination of the relatively crude fraction used
by adenylate kinase, which would generate AMP
(2ADP ↔ ATP + AMP) from ADP formed in the kinase or
other ATPase reactions. A rigorous test of the hypothesis
that AMP is an activating signal in the SNF1 system will
therefore require further purification of SRF, and reconsti-
tution of the cascade from highly purified components.
The measurements of adenine nucleotides in vivo (see
below) do provide circumstantial evidence for the hypothe-
sis that increases in AMP (or in the AMP:ATP ratio) is the
signal(s) that activates the SNF1 protein kinase cascade
under derepressing conditions. Intriguingly, reactivation of
SNF1 by SRF in the DEAE–Sepharose fraction did not
occur if the extract was from cells prepared under repress-
ing conditions (Fig. 2b). This suggests that SRF activity is
regulated by glucose availability, although the mechanism
remains unclear.
Carlson’s group previously found that the protein kinase
activity of SNF1 was essential for its function [11], but
reported that it was not changed on transfer from repress-
ing to derepressing conditions [6]. On the other hand,
Woods et al. [10] reported that SNF1 kinase was activated
by removal of glucose, although the effect was small
(approximately 3-fold) and was not maximal until
90 minutes after removal of glucose. In contrast to these
results, we found that SNF1 was activated maximally
within 5 minutes after removal of glucose, and that the
effect was greater than 10-fold (Figs 1,3). The real effect is
probably much larger than this, because the activity
obtained under derepressing conditions was similar to that
obtained in a snf1-knockout strain (Fig. 1). As the effect
could be completely reversed by adding PP2A to the lysate
(Fig. 1c), it appears to be due to phosphorylation, presum-
ably of Snf1p by SRF. We believe there are two potential
reasons for the apparent discrepancies between our find-
ings and those of previous workers. First, the effect was
only observed if the cells were harvested by rapid filtration
and freezing; if they were harvested by centrifugation and
resuspension in homogenization medium lacking glucose,
as apparently used by Carlson’s group [6], SNF1 kinase
was fully activated even under derepressing conditions
(Fig. 1b). This is a reflection of the rapidity with which
activation occurs on glucose removal (Fig. 3), and is remi-
niscent of previous findings with the rat liver homologue,
AMPK, where freeze clamping is essential to preserve the
in vivo phosphorylation state [33]. Woods et al. [10] used
centrifugation to harvest the cells, but froze them in liquid
nitrogen prior to homogenization. It is possible that this
protocol partially preserved the in vivo activation state of
SNF1. Second, we assayed SNF1 immediately in crude
extracts, whereas the other workers first purified the
kinase either by renaturation after gel electrophoresis and
blotting [6], or by DEAE–Sepharose chromatography [10].
It is possible that the effect of glucose removal on SNF1
activity is not fully preserved by these protocols.
With the cell-free preparations available to us, we were
unable to obtain unequivocal evidence that AMP causes
activation of the SNF1 protein kinase cascade in vitro,
although there were correlations between the levels of
adenine nucleotides and SNF1 activity in vivo under all
conditions examined. The transfer of cells from high (2 %)
to low (0.05 %) glucose caused rapid, greater than 200-fold
increases in the cellular AMP:ATP ratio, and smaller rises
in the ADP:ATP ratio. Correlations between AMP:ATP
ratio (and ADP:ATP) and SNF1 kinase activity were also
evident when the experimental variable was the glucose
concentration, although the nucleotide ratios appeared to
be affected by a slightly lower range of glucose concentra-
tions than kinase activity (Fig. 4). This is not necessarily
inconsistent with our hypothesis, because with the very
high nucleotide ratios observed in completely derepressed
cells it seems likely that kinase activation system would
be saturated.
We therefore propose as a working hypothesis that high
AMP (or, by analogy with the AMPK system, a high
AMP:ATP ratio) may be the signal for activation of SNF1
when glucose is removed from the medium. Previous
hypotheses regarding the signal(s) for glucose repression
and derepression have centred around hexokinase and
glucose-6-phosphate, but we believe that our hypothesis is
compatible with all previous genetic and biochemical data.
Entian [34] reported that hex1 mutants, which gave consti-
tutive expression of some glucose-repressed genes, were
allelic to HXK2, which encodes the PII isoform of hexoki-
nase. By contrast, the activity of the next enzyme in glycol-
ysis, phosphoglucose isomerase, could be reduced 100-fold
without apparent effect on glucose repression [35]; this sug-
gested a role for glucose-6-phosphate as a positive signal in
glucose repression. However, given that S. cerevisiae grown
on glucose uses glycolysis as the primary method of ATP
production, a reduction of hexokinase activity would also be
expected to deplete ATP and elevate the AMP:ATP ratio.
In our hands, glucose-6-phosphate had no effect on SNF1
activity, or on reactivation of SNF1 by SRF. Negative
results were also obtained with a wide range of other sugar
phosphates which are intermediates or regulators of glycoly-
sis, gluconeogenesis or the pentose phosphate pathway.
The other evidence for a role for hexose phosphates 
in glucose repression is that analogues of glucose such as 
2-deoxyglucose [36] and 3-O-methylglucose [37] can
mimic the repressive effects of glucose. These compounds
are phosphorylated by hexokinases to the corresponding 6-
phosphates, but are not metabolized further by glycolysis,
and the results were taken as evidence that metabolism
beyond hexose phosphates was not necessary to generate
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the glucose repression signal. A potential problem with
this interpretation is that intracellular phosphorylation of
these analogues rapidly depletes cellular ATP. We found
that, even in the presence of 2 % glucose, 2-deoxyglucose
caused a 67 % decline in ATP at 1 mM and 97 % at 40 mM
(data not shown; Witt et al. [36] used 15–180 mM). In cells
briefly starved of glucose (where there were already 260-
and 40-fold rises in AMP:ATP and ADP:ATP), the readdi-
tion of 50 mM 2-deoxyglucose caused these ratios to rise
even further (9-fold and 3-fold respectively). We therefore
believe that the results with ‘non-metabolizable’ ana-
logues of glucose are a reflection of the toxicity of these
compounds, which may reduce cellular ATP to such low
levels that it can no longer support the protein kinase
activity of SNF1 and/or SRF.
Conclusions
Our current working hypothesis for the mechanism of
repression and derepression of genes in S. cerevisiae in
response to the availability of glucose is summarized in
Figure 6. Rapid fermentation produces a high ATP:ADP
ratio, and this displaces the adenylate kinase reaction
(2ADP ↔ ATP + AMP) towards ADP, maintaining AMP
at a low level. The prevailing low ratio of AMP:ATP does
not promote phosphorylation of Snf1p by the SRF, and
protein phosphatase(s) (as yet unidentified) maintain the
SNF1 complex in its inactive, dephosphorylated form.
When glucose is removed from the medium, or glucose is
replaced by an alternative carbon source such as sucrose,
fermentation ceases due to lack of an immediately metab-
olizable carbon source, and a continuation of ATP-con-
suming pathways results in a rapid drop in the ATP:ADP
ratio. The adenylate kinase reaction is now displaced in
the direction of AMP formation, and there is an abrupt rise
in the AMP:ATP ratio. This promotes phosphorylation of
Snf1p by SRF, dramatically increasing the protein kinase
activity of the SNF1 complex.
The model shown in Figure 6 also depicts possible events
downstream of SNF1, based on the work of others. A
number of genes acting downstream of SNF1 have been
identified [2]. Many appear to encode general transcription
factors which are also involved in expression of genes not
controlled by glucose. A notable exception is the MIG1
gene, which encodes a Cys-His zinc finger DNA-binding
protein that appears to bind specifically to promoters of
glucose-regulated genes [38]. There is evidence that Mig1p
is phosphorylated under derepressing conditions [39], and
an attractive hypothesis is that it is phosphorylated directly
by the activated SNF1 complex. This may prevent interac-
tion with the co-repressors Ssn6p/Tup1p and convert the
repressor complex into an activator [39].
The evidence that elevation of AMP (or the AMP/ATP
ratio) is the signal which triggers derepression is currently
only circumstantial. However, given the close similarity
between the yeast SNF1 and the mammalian AMP-
activated protein kinase systems, we regard adenine nuc-
leotides as prime candidates to be these signals. Although
certain aspects of our model are speculative, they are
readily amenable to further experimental testing.
Materials and methods
Materials
Biochemicals were from Boehringer, Sigma, or Calbiochem-Nov-
abiochem. All other reagents were analytical reagent grade from
Merck-BDH. The SAMS peptide (HMRSAMSGLHLVKRR) was synthe-
sized as described previously [30]. PP1 (human g catalytic subunit
expressed in E. coli [40]), PP2A (catalytic subunit purified from bovine
heart using a procedure described for rabbit muscle [41]) and PP2C
(human a isoform expressed in E. coli [23]) were gifts from Robert
MacKintosh (PP1, PP2A) and Nicholas Helps (PP2C). AMPKK was
purified from rat liver as far as the Q Sepharose step [31].
Yeast strains, media, and culture
The following yeast strains were used and, unless stated otherwise,
were gifts from Michael Stark:
ABYS106 (mating type unknown) pra1-1 prb1-1 prc1-1 cps1-3 his3
ura3 leu2 
AY925 MATa ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1
can1-100 ssd1-d2
AY926 MATa, otherwise as AY925
YPH499 MATa ura3-52 lys2-801am ade2-101oc trp1-D63
his3-D200
Figure 6
A working model for the role of the SNF1 protein kinase in
repression/derepression of the SUC2 (invertase) gene. See
Discussion for a full description. More speculative components of the
model are indicated by question marks. Pathways which predominate
under repressing conditions (high glucose) are shown in red; pathways
which predominate under derepressing conditions (low glucose) are
shown in green.
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MCY1094 MATa ade2-101 ura3-52 (from Marian Carlson)
MCY1828 MATa snf1-D10 ade2-101 ura3-52 (from Marian Carlson)
For routine growth at 28 °C, YP medium (1 % (by mass) yeast extract,
2 % (by mass) bactopeptone) was supplemented with glucose as indi-
cated in the text. Cells were normally grown to a density of
~107 cells ml–1. Small cultures (200 ml) were grown in 1 l conical
flasks in an orbital shaker at 250 rpm. Large-scale cultures (25 l) were
grown in a 28 l New Brunswick pilot plant. The chamber was stirred at
250 rpm and air provided at 6.5 l min–1. The culture was concentrated
to ∼1 l using a Millipore Pellicon concentration device with a 0.45 mm
filter. For both large- and small-scale cultures the cells were finally har-
vested by centrifugation (1000 × g, 10 min), washed once by resus-
pension in homogenization buffer and recentrifugation, and
resuspended to 1 g ml–1 in the same buffer. In experiments where the
carbon source was removed or exchanged, cells were transferred to
sterile tubes, centrifuged (2000 × g, 2 min), resuspended in the new
medium, recentrifuged, and resuspended in the medium again.
Enzyme assays
SNF1 kinase was assayed as described for AMPK but without AMP
[30]. Protein phosphatases were assayed as described [41,42]. Units
of kinase/phosphatase are nmol phosphate transferred per min at
30 °C. AMP-activated protein kinase kinase (AMPKK) was assayed as
described [31].
Preparation of small scale yeast extracts
Cells (∼107 ml–1) were collected by rapid filtration on nylon-66 filters
(0.45 mm pore size) and the cell cake scraped off and immediately
frozen in liquid nitrogen. Homogenization was carried out by transfer-
ring the cell cake to a 1.5 ml microcentrifuge tube containing 300 ml
glass beads (acid-washed, 0.4 mm) and 150 ml of 50 mM Na Hepes,
pH 7.0, 50 mM NaF, 50 mM NaCl, 1 mM EDTA, 10 % (by vol) glycerol,
1 mM dithiothreitol, 1 mM benzamidine, 5 mg ml–1 soybean trypsin
inhibitor and 1 mM phenylmethane sulphonyl fluoride (PMSF). The
mixture was vortexed 5 times for 30 sec, with 2 min on ice between
each mixing. Subsequent steps were performed at 4 °C. A small hole
was punched in the base of the tube, which was placed inside another
tube and spun in a bench centrifuge (1000 × g, 1 min) to remove the
glass beads. Cell debris was removed in a microcentrifuge
(14 000 × g, 1 min) and the supernatant used for SNF1 assays.
Purification of SNF1
Yeast cells (∼40 g), frozen in homogenization buffer (50 mM Tris–HCl,
pH 8.4 at 4 °C, 2 M NaCl, 50 mM NaF, 5 mM Na pyrophosphate, 1 mM
EGTA, 1 mM EDTA and 1 mM dithiothreitol) were thawed and protease
inhibitors (benzamidine (1 mM), soybean trypsin inhibitor (5 mg ml–1),
PMSF (1 mM) and leupeptin (3 mg ml–1)) plus dithiothreitol (1 mM) and
antifoam A concentrate (0.02 % by volume) were added to the indi-
cated final concentrations. Aliquots (≈ 30 ml) were homogenized with
an equal volume of 0.4 mm acid-washed glass beads in a Braun mill
with liquid CO2 cooling for 1 min at 4000 rpm. The beads were
allowed to settle, the extract decanted, the beads washed with
5 volumes of homogenizing buffer and the wash combined with the
extract. SNF1 was purified essentially as described by Mitchelhill [16],
concentrated by centrifugation through a Centricon-30 filter (Amicon),
made 30 % (by volume) with ethanediol and stored at –20 °C.
Other analytical procedures and expression of results
For nucleotide analysis, cells (∼4 × 108) were collected by rapid filtration
and immediately scraped into a microcentrifuge tube containing 600ml
of 5 % (by mass) ice-cold HClO4 and 600 ml of 0.4 mm glass beads.
After vigorous vortex mixing for 30 sec, the glass beads were removed as
described above, and nucleotides analysed by HPLC as described previ-
ously [19]. Determination of protein concentration [43], PAGE, silver
staining and western blotting were by standard methods. Where quanti-
tative results are expressed in the text, they are means ± standard errors
of the mean, with the number of experiments in parentheses.
Dephosphorylation and reactivation of SNF1
SNF1 was purified as above except that NaF in the Ni2+-Sepharose
buffer was replaced by NaCl, and the kinase was diluted to
∼10 units ml–1 in 50 mM Na Hepes, pH 7.0, 0.1 % (by volume) Triton
X-100, 1 mM dithiothreitol. It was incubated with PP1, PP2A or PP2C
at 30 °C, and aliquots were removed at intervals and diluted in buffer
containing 10 nM okadaic acid (PP1, PP2A) or 50 mM NaF (PP2C)
before the kinase assay. When using PP2C, 20 mM MgCl2 was added
to the phosphatase incubation. For reactivation experiments using
AMPKK, SNF1 was dephosphorylated for 10 min using PP2A
(10 U ml–1). Dephosphorylation was stopped by adding okadaic acid to
100 nM, and aliquots were added to reactivation assays containing
5 mM MgCl2, 200 mM ATP in 50 mM Na Hepes, pH 7.0, 0.02 % (by
mass) Brij-35. AMPKK (5 U ml–1) was added and the mixture incubated
at 30 °C. For these assays the peptide AMARAASAAALARRR was
used in place of the SAMS peptide, because the AMPKK preparation
contains a kinase which slowly phosphorylates the latter [31]. For reac-
tivation experiments using endogenous SRF, SNF1 was purified to the
DEAE–Sepharose step, but replacing the NaF in the elution buffer with
NaCl (500 mM final concentration). Dephosphorylation was carried out
as before but was stopped with 100 nM okadaic acid plus 50 mM NaF
(the latter to inhibit endogenous PP2C).
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